Get started
ICBC CREDIT SUISSE ASSET MGT CO LTD CSI BRAND NAME DRUG INDUSTRY IDX ETF CNYICBC CREDIT SUISSE ASSET MGT CO LTD CSI BRAND NAME DRUG INDUSTRY IDX ETF CNYICBC CREDIT SUISSE ASSET MGT CO LTD CSI BRAND NAME DRUG INDUSTRY IDX ETF CNY

ICBC CREDIT SUISSE ASSET MGT CO LTD CSI BRAND NAME DRUG INDUSTRY IDX ETF CNY

No trades
See on Supercharts
Overview
Analysis
Discussions Technicals Seasonals

Key stats


Assets under management (AUM)
‪112.39 M‬ CNY
Fund flows (1Y)
‪−8.00 M‬ CNY
Dividend yield (indicated)
—
Discount/Premium to NAV
0.02%
Shares outstanding
‪241.24 M‬
Expense ratio
0.52%

About ICBC CREDIT SUISSE ASSET MGT CO LTD CSI BRAND NAME DRUG INDUSTRY IDX ETF CNY


Issuer
ICBC Credit Suisse Asset Management Co., Ltd.
Brand
ICBC
Home page
icbccs.com.cn
Inception date
Feb 9, 2021
Structure
Open-Ended Fund
Index tracked
CSI Innovative Drug Industry Index - CNY - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Primary advisor
ICBC Credit Suisse Asset Management Co., Ltd.
ISIN
CNE100004FV2
Closely track the underlying index, Tightly track the target and minimize the deviation, and strive to achieve long-term investment returns consistent with the performance of the underlying index.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Pharmaceuticals
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance——————
NAV total return——————

What's in the fund


As of June 30, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks98.45%
Health Technology91.48%
Commercial Services6.96%
Bonds, Cash & Other1.55%
Cash1.55%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows